Pharmaceutical composition comprising a factor VII polypeptide and epsilon-aminocaproic acid
OwnerRasmus Rojkjaerinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising factor VII or a factor VII-related poly-peptide and epsilon-aminocaproic acid, and the use thereof for treating bleeding episodes.
Claims23
A pharmaceutical composition comprising a factor VII-related polypeptide and epsilon-aminocaproic acid.
A kit comprising
- a) A preparation of a factor VII-related polypeptide and a pharmaceutically acceptable carrier in a first-unit dosage form;
- b) A preparation of epsilon-aminocaproic acid and a pharmaceutically acceptable carrier in a second-unit dosage form;
- and
- c) Container means for containing said first and second dosage forms.
A method for treating bleeding in a subject, the method comprising administering to a subject in need thereof a first amount of a preparation of a factor VII-related polypeptide and a second amount of a preparation of epsilon-aminocaproic acid, wherein the first and second amount together are effective to treat bleedings.
A kit containing a treatment for bleeding episodes comprising
- a) An effective amount of a factor VII-related polypeptide and an effective amount of epsilon-aminocaproic acid and a pharmaceutically acceptable carrier in a single-unit dosage form;
- and
- b) Container means for containing said single-unit dosage form.
A method for treating bleeding in a non-hemophilica subject, the method comprising administering to a subject in need thereof a first amount of a preparation of a factor VII-related polypeptide and a second amount of a preparation of epsilon-aminocaproic acid, wherein the first and second amount together are effective to treat bleedings.
Dependencies are inferred from the claim text.